News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,734 Results
Type
Article (13948)
Company Profile (304)
Press Release (247482)
Section
Business (79360)
Career Advice (151)
Deals (13193)
Drug Delivery (34)
Drug Development (50328)
Employer Resources (31)
FDA (5684)
Job Trends (5116)
News (144146)
Policy (10022)
Tag
Academia (902)
Alliances (21527)
Alzheimer's disease (756)
Approvals (5663)
Artificial intelligence (68)
Bankruptcy (97)
Best Places to Work (4522)
Biotechnology (249)
Breast cancer (109)
Cancer (888)
Cardiovascular disease (71)
Career advice (132)
CAR-T (73)
Cell therapy (217)
Clinical research (40137)
Collaboration (309)
Compensation (128)
COVID-19 (1006)
C-suite (78)
Cystic fibrosis (66)
Data (983)
Diabetes (85)
Diagnostics (1207)
Drug discovery (56)
Earnings (29006)
Events (47193)
Executive appointments (247)
FDA (6049)
Funding (306)
Gene editing (63)
Gene therapy (163)
GLP-1 (310)
Government (1066)
Healthcare (6543)
Infectious disease (1044)
Inflammatory bowel disease (98)
IPO (7198)
Job creations (859)
Job search strategy (127)
Layoffs (188)
Legal (1375)
Lung cancer (130)
Lymphoma (62)
Manufacturing (86)
Medical device (2558)
Medtech (2559)
Mergers & acquisitions (6130)
Metabolic disorders (257)
Neuroscience (999)
NextGen Class of 2024 (2004)
Non-profit (847)
Northern California (1091)
Obesity (140)
Opinion (91)
Parkinson's disease (75)
Patents (61)
People (25103)
Phase I (14150)
Phase II (18664)
Phase III (11818)
Pipeline (368)
Postmarket research (851)
Preclinical (5971)
Radiopharmaceuticals (205)
Rare diseases (201)
Real estate (1409)
Regulatory (8284)
Research institute (932)
Southern California (976)
Startups (1964)
United States (8657)
Vaccines (164)
Weight loss (83)
Date
Today (23)
Last 7 days (364)
Last 30 days (1469)
Last 365 days (20552)
2024 (20442)
2023 (22413)
2022 (26822)
2021 (27806)
2020 (23359)
2019 (16226)
2018 (11742)
2017 (13747)
2016 (11839)
2015 (14350)
2014 (10395)
2013 (7486)
2012 (7533)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16923)
Australia (2856)
California (2475)
Canada (809)
China (203)
Colorado (91)
Connecticut (103)
Europe (36453)
Florida (271)
Georgia (71)
Illinois (153)
Indiana (62)
Kansas (55)
Maryland (330)
Massachusetts (1955)
Minnesota (101)
New Jersey (630)
New York (682)
North Carolina (419)
Northern California (1091)
Ohio (82)
Pennsylvania (474)
South America (207)
Southern California (976)
Texas (278)
Washington State (247)
261,734 Results for "seres therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
December 16, 2024
·
5 min read
Press Releases
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
November 22, 2024
·
1 min read
Deals
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science
Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual property rights.
June 6, 2024
·
5 min read
Press Releases
Seres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 13, 2024
·
16 min read
Business
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Seres Therapeutics, Inc., a leading microbiome therapeutics company, reported first quarter 2024 financial results and provided business updates.
May 8, 2024
·
13 min read
Press Releases
Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024
November 6, 2024
·
1 min read
Press Releases
Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference
September 13, 2024
·
1 min read
Genetown
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 07, 2024
Seres Therapeutics, Inc. announced that on June 5, 2024, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 6,188 shares of its common stock to one new employee, consisting of stock options to purchase 4,125 shares of common stock and restricted stock units covering 2,063 shares of its common stock.
June 7, 2024
·
1 min read
Genetown
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
Seres Therapeutics, Inc. announced today that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will participate in a panel discussion at the Cowen 44th Annual Health Care Conference on Wednesday, March 6, 2024 at 9:10 a.m. ET.
February 27, 2024
·
1 min read
Press Releases
FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
December 9, 2024
·
9 min read
1 of 26,174
Next
